Abstract:Tetrandrine (Tet) is a bisbenzylisoquinoline alkaloid isolated from the root of Stephania tetrandra, which has been used in traditional Chinese medicine to treat patients with silicosis, asthma, and pulmonary hypertension, and others and can be used as a pulmonary therapeutic agent. We hypothesized that it can also improve the lung growth in congenital diaphragmatic hernia (CDH) for its multiple biological effects. There are increasing evidences that suggest transforming growth factor beta1(TGF-beta1) plays a crucial role in fetal lung growth and morphogenesis. The aim of this study was to evaluate the effect of prenatal administration of Tet and to investigate its possible mechanism on the expression of TGF-beta1 in the lung of nitrofen-induced CDH rat model.A CDH model was induced in pregnant Sprague-Dawley rats by administration of nitrofen on day 9.5 of gestation (Ed9.5 term, day 22). Tetrandrine (30 mg/kg) was given through gavage (once a day, for 3 days) on Ed11.5. Accordingly, there were 3 groups as follows: control (n = 9), CDH (n = 9), and CDH + Tet (n = 9). All the fetuses were delivered by cesarean delivery on Ed16.5, 18.5, and 21.5, respectively, to check if diaphragmatic hernia existed on each fetus, then the lung tissue weight (LW) and body weight (BW) of each fetus were recorded. Histologic evaluations and TGF-beta1 immunohistochemistry staining in the lung sample were performed for image analysis.Diaphragmatic hernia was observed in 95 of the 112 rat fetuses in CDH and CDH + Tet groups on Ed18.5 and Ed21.5 (84.8%), the incidence between the 2 groups had no statistical significance (P = .642). Lung weight/body weight in the CDH group and the CDH + Tet group were lower than that in the control group (P < .01), and LW/BW in the CDH group was lower than that in the CDH + Tet group (P < .05). Observed under the light microscope and electron microscope, marked hypoplasia of the lungs in fetuses among the CDH groups was observed, in contrast to improvement of the lungs in CDH + Tet fetuses. Statistical differences in morphological parameters (percentage of alveoli area, counting bronchus) were found even on Ed16.5 when diaphragm had not closed (P < .01). The number of type II pneumocytes and lamellar bodies in each group had no significant difference (P > .05). The immunoreactivity of TGF-beta1 in CDH group and CDH + Tet group were markedly stronger than that in the control group (P < .01). In addition, TGF-beta1 expression in the CDH group was stronger than that in the CDH + Tet group (P < .01).Nitrofen can interfere with lung development early in the fetal rat development before and separate from diaphragm development, and increased expression of TGF-beta1 in the lung of CDH rat model may suppress lung growth and development. Prenatal treatment with Tet can improve the growth of the lung of the nitrofen-induced CDH fetuses and its mechanism seems to be involved in downregulating the expression of TGF-beta1. It is a likely new approach to treat CDH and its coexistent lung hypoplasia by maternal Tet administration.

Nitrofen-induced murine pulmonary hypoplasia of congenital diaphragmatic hernia

[A Series of Observation on the Expression of TGF-beta1 in the Lung of Nitrofen-Induced Congenital Diaphragmatic Hernia Rat Model].

Dynamic Expression of TNF-α and IL-1β in Nitrofen-Induced Congenital Diaphragmatic Hernia Rat Model

Expression of Hypoxia-Induced Mitogenic Factor in Fetal Lungs of Congenital Diaphragmatic Hernia in Mice

Sequential Ultramicrostructural Observation on the Hypoplastic Lung of Fetal Rat Model of Congenital Diaphragmatic Hernia

Ultrastructural changes of pulmonary arteries in nitrofen-induced congenital diaphragmatic hernia rats

Effect of Estradiol on Lung Development in Murine Nitrofen Model of Congenital Diaphragmatic Hernia

[Effect of Tetrandrine on Lung Development: Experiment of Nitrofen-Induced Congenital Diaphragmatic Hernia Fetal Rat Model].

Decreased expression of monocarboxylate transporter 1 and 4 in the branching airway epithelium of nitrofen-induced congenital diaphragmatic hernia

Differential gene expression at gestational days 14 and 16 in normal and nitrogen-induced hypoplastic murine fetal lungs with coexistent diaphragmatic hernia.

Effect of prenatal tetrandrine administration on transforming growth factor-β1 level in the lung of nitrofen-induced congenital diaphragmatic hernia rat model

The effects of prenatal tetrandrine treatment on pulmonary vascular development and CTGF expression in rats with congenital diaphragmatic hernia

Effect of Epidermal Growth Factor on Pulmonary Hypoplasia in Experimental Diaphragmatic Hernia.

The Effect of Prenatal Tetrandrine Treatment on Pulmonary Hypoplasia in Fetal Rats with Nitrofen-Induced Congenital Diaphragmatic Hernia

[Effect of Ambroxol on Lung Development of Rat Models with Nitrofen-Induced Congenital Diaphragmatic Hernia].

Sonic hedgehog gene expression in nitrofen induced hypoplastic lungs in mice

MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia

The effect of ASK1-P38 α/JNK pathway on pulmonary vessels in nitrofen induced congenital diaphragmatic hernia

Genetically Modified Mouse Models of Congenital Diaphragmatic Hernia: Opportunities and Limitations for Studying Altered Lung Development

The Expression of Fibroblast Growth Factor-7 in the Fetal Lungs of Nitrofen-Induced Diaphragmatic Hernia in Rats

Intervention of L-nitro-arginine Methyl Ester in Pulmonary Arterioles Development of Rats with Congenital Diaphragmatic Hernia